Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A

Journal of Virology

Volumn 88, Issue 6, 2014, Pages 3246-3254

  Ramière, Christophe ^a,b,c,d   Rodriguez, Jonathan ^a,b,c   Enache, Liviu S ^e,f   Lotteau, Vincent ^a,b,c   André, Patrice ^a,b,c,d   Diaz, Olivier ^a,b,c  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c CNRS   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f Emergency Clinical Hospital   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

HEXOKINASE; LACTIC ACID; NONSTRUCTURAL PROTEIN 5A;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE INTAKE; GLYCOLYSIS; HEPATITIS C; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REPLICON;

CELL LINE; GLUCOSE; GLYCOLYSIS; HEPACIVIRUS; HEPATITIS C; HEXOKINASE; HUMANS; PROTEIN BINDING; UP-REGULATION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84894539241     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02862-13     Document Type: Article

References (41)

1. Scheel TKH, Rice CM. 2013. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat. Med. 19:837-849. http://dx.doi.org/10.1038/nm.3248.
2. Ye J. 2007. Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus. PLoS Pathog. 3:e108. http://dx.doi.org/10.1371/journal.ppat.0030108.
3. Kapadia SB, Chisari FV. 2005. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. U.S.A. 102:2561-2566. http://dx.doi.org/10.1073/pnas.0409834102.
4. Popescu C-I, Dubuisson J. 2010. Role of lipid metabolism in hepatitis C virus assembly and entry. Biol. Cell 102:63-74. http://dx.doi.org/10.1042/BC20090125.
5. Icard V, Diaz O, Scholtes C, Perrin-Cocon L, Ramière C, Bartenschlager R, Penin F, Lotteau V, André P. 2009. Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS One 4:e4233. http://dx.doi.org/10.1371/journal.pone.0004233.
6. Jiang J, Luo G. 2009. Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J. Virol. 83:12680-12691. http://dx.doi.org/10.1128/JVI.01476-09.
7. Bartenschlager R, Penin F, Lohmann V, André P. 2011. Assembly of infectious hepatitis C virus particles. Trends Microbiol. 19:95-103. http://dx.doi.org/10.1016/j.tim.2010.11.005.
8. Andre P, Komurian-Pradel F, Deforges S, Perret M, Berland J, Sodoyer M, Pol S, Brechot C, Paranhos-Baccala G, Lotteau V. 2002. Characterization of low-and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 76:6919-6928. http://dx.doi.org/10.1128/JVI.76.14.6919-6928.2002.
9. Diaz O, Delers F, Maynard M, Demignot S, Zoulim F, Chambaz J, Trépo C, Lotteau V, André P. 2006. Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins. J. Gen. Virol. 87:2983-2991. http://dx.doi.org/10.1099/vir.0.82033-0.
10. Diaz O, Cubero M, Trabaud MA, Quer J, Icard V, Esteban JI, Lotteau V, André P. 2008. Transmission of low-density hepatitis C viral particles during sexually transmitted acute resolving infection. J. Med. Virol. 80: 242-246. http://dx.doi.org/10.1002/jmv.21037.
11. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, McKeating JA, Lanford RE, Feinstone SM, Major ME, Leroux-Roels G, Rice CM. 2006. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc. Natl. Acad. Sci. U.S.A. 103:3805-3809. http://dx.doi.org/10.1073/pnas.0511218103.
12. Steenbergen RHG, Joyce MA, Thomas BS, Jones D, Law J, Russell R, Houghton M, Tyrrell DL. 2013. Human serum leads to differentiation of human hepatoma cells, restoration of VLDL secretion and a 1000-fold increase inHCVJFH-1 titers. Hepatology 58:1907-1917. http://dx.doi.org/10.1002/hep.26566.
13. Patel JH, Cobbold JFL, Thomas HC, Taylor-Robinson SD. 2010. HepatitisCand hepatic steatosis.QJM103:293-303. http://dx.doi.org/10.1093/qjmed/hcp192.
14. Roingeard P. 2013. Hepatitis C virus diversity and hepatic steatosis. J. Viral Hepat. 20:77-84. http://dx.doi.org/10.1111/jvh.12035.
15. Diamond DL, Syder AJ, Jacobs JM, Sorensen CM, Walters K-A, Proll SC, McDermott JE, Gritsenko MA, Zhang Q, Zhao R, Metz TO, Camp DG, II, Waters KM, Smith RD, Rice CM, Katze MG. 2010. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 6:e1000719. http://dx.doi.org/10.1371/journal.ppat.1000719.
16. Levy HB, Baron S. 1957. The effect of animal viruses on host cell metabolism. II. Effect of poliomyelitis virus on glycolysis and uptake of glycine by monkey kidney tissue cultures. J. Infect. Dis. 100:109-118.
17. Henle G, Deinhardt F, Bergs VV, Henle W. 1958. Studies on persistent infections of tissue cultures. I. General aspects of the system. J. Exp. Med. 108:537-560.
18. Vastag L, Koyuncu E, Grady SL, Shenk TE, Rabinowitz JD. 2011. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 7:e1002124. http://dx.doi.org/10.1371/journal.ppat.1002124.
19. Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD. 2006. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2:e132. http://dx.doi.org/10.1371/journal.ppat.0020132.
20. Munger J, Bennett BD, Parikh A, Feng X-J, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD. 2008. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26:1179-1186. http://dx.doi.org/10.1038/nbt.1500.
21. Hanoulle X, Badillo A, Wieruszeski J-M, Verdegem D, Landrieu I, Bartenschlager R, Penin F, Lippens G. 2009. Hepatitis C virus NS5A protein is a substrate for the peptidyl-prolyl cis/trans isomerase activity of cyclophilins A and B. J. Biol. Chem. 284:13589-13601. http://dx.doi.org/10.1074/jbc.M809244200.
22. Verdegem D, Badillo A, Wieruszeski J-M, Landrieu I, Leroy A, Bartenschlager R, Penin F, Lippens G, Hanoulle X. 2011. Domain 3 of NS5A protein from the hepatitis C virus has intrinsic α-helical propensity and is a substrate of cyclophilin A. J. Biol. Chem. 286:20441-20454. http://dx.doi.org/10.1074/jbc.M110.182436.
23. Boulant S, Vanbelle C, Ebel C, Penin F, Lavergne J-P. 2005. Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features. J. Virol. 79:11353-11365. http://dx.doi.org/10.1128/JVI.79.17.11353-11365.2005.
24. Cassonnet P, Rolloy C, Neveu G, Vidalain PO, Chantier T, Pellet J, Jones L, Muller M, Demeret C, Gaud G, others. 2011. Benchmarking a luciferase complementation assay for detecting protein complexes. Nat. Methods 8:990-992. http://dx.doi.org/10.1038/nmeth.1773.
25. Merz A, Long G, Hiet M-S, Brügger B, Chlanda P, Andre P, Wieland F, Krijnse-Locker J, Bartenschlager R. 2011. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J. Biol. Chem. 286:3018-3032. http://dx.doi.org/10.1074/jbc.M110.175018.
26. De Chassey B, Navratil V, Tafforeau L, Hiet MS, Aublin-Gex A, Agaugué S, Meiffren G, Pradezynski F, Faria BF, Chantier T, Le Breton M, Pellet J, Davoust N, Mangeot PE, Chaboud A, Penin F, Jacob Y, Vidalain PO, Vidal M, André P, Rabourdin-Combe C, Lotteau V. 2008. Hepatitis C virus infection protein network. Mol. Syst. Biol. 4:230. http://dx.doi.org/10.1038/msb.2008.66.
27. Ronco LV, Karpova AY, Vidal M, Howley PM. 1998. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:2061-2072. http://dx.doi.org/10.1101/gad.12.13.2061.
28. Evan GI, Lewis GK, Ramsay G, Bishop JM. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610-3616.
29. Neary CL, Pastorino JG. 2013. Akt inhibition promotes hexokinase 2 redistribution and glucose uptake in cancer cells. J. Cell. Physiol. 228: 1943-1948. http://dx.doi.org/10.1002/jcp.24361.
30. Saks V. 2007. Molecular system bioenergetics: energy for life. Wiley-VCH, Weinheim, Germany.
31. Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029-1033. http://dx.doi.org/10.1126/science.1160809.
32. Robey RB, Hay N. 2006. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25:4683-4696. http://dx.doi.org/10.1038/sj.onc.1209595.
33. Mathupala SP, Ko YH, Pedersen PL. 2009. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg effect" and a pivotal target for effective therapy. Semin. Cancer Biol. 19:17-24. http://dx.doi.org/10.1016/j.semcancer.2008.11.006.
34. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319:921-926. http://dx.doi.org/10.1126/science.1152725.
35. König R, Zhou Y, Elleder D, Diamond TL, Bonamy GMC, Irelan JT, Chiang C-Y, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP, Miraglia LJ, Bushman FD, Young JA, Chanda SK. 2008. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135:49-60. http://dx.doi.org/10.1016/j.cell.2008.07.032.
36. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth AS. 2008. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4:495-504. http://dx.doi.org/10.1016/j.chom.2008.10.004.
37. Fusco DN, Brisac C, John SP, Huang Y-W, Chin CR, Xie T, Zhao H, Jilg N, Zhang L, Chevaliez S, Wambua D, Lin W, Peng L, Chung RT, Brass AL. 2013. A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication. Gastroenterology 144:1438-1449.e9. http://dx.doi.org/10.1053/j.gastro.2013.02.026.
38. Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao Y, Feng Y, Li L, Wang Y, Liu X, Chen H, Liu X-Y, Ji H. 2012. MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J. Biol. Chem. 287: 23227-23235. http://dx.doi.org/10.1074/jbc.M112.373084.
39. Cheng M, Si Y, Niu Y, Liu X, Li X, Zhao J, Jin Q, Yang W. 2013. High-throughput profiling of alpha interferon-and interleukin-28Bregulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1. J. Virol. 87:9707-9718. http://dx.doi.org/10.1128/JVI.00802-13.
40. Monakhov NK, Neistadt EL, Shavlovskil MM, Shvartsman AL, Neifakh SA. 1978. Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J. Natl. Cancer Inst. 61:7-34.
41. Bergmeyer HU, Grassl M, Walter HE. 1983. Methods of enzymatic analysis, 3rd ed, vol 2, p 222-223. Verlag Chemie, Deerfield Beach, FL.